Board and Executive Management

Board

Jörg-Michael Rupp, Roche (President)

Katharina Gasser, Biogen Switzerland AG (Vicepresident)

Anita Ouwerkerk, Novartis (Vicepresident)

Urs Vögeli, Johnson & Johnson (Vicepresident)

Henrik Asmussen, Amgen

Sabine Bruckner, Pfizer

René P. Buholzer, Interpharma (Delegierter des Vorstands)

Katrien DeVos, AstraZeneca

Christophe Griolet, Gilead Science

Remo Gujer, Bristol-Myers Squibb

Ans Heirman, MSD

Colleen Kamrad, GSK

Matthias Leuenberger, Novartis

Andrea Michael Meyer, Sanofi

Pierre Morneau, Takeda

Leila Schwery-Bou-Diab, Johnson & Johnson

Nathalie Stieger, F. Hoffmann-La Roche

Mads Stoustrup, Novo Nordisk

Executive management

Dr. René P. Buholzer

Managing director

Susanne Müller

Member of the Executive Board / Services

Markus A. Ziegler

Member of the Executive Board / Head of Markets

Yves Weidmann

Member of the Executive Board / Head of Governmental Affairs

Samuel Lanz

Member of the Executive Board / Head of Communications

+41 61 264 34 85

Dr. Tanja Colin

Member of the Executive Board / Head of Approval & Technology

Simon Fry

Member of the Executive Board / Head of Innovation & IPR

Media contacts

Michèle Sierro

Communication Manager Romandie

+41 79 305 84 30

Samuel Lanz

Member of the Executive Board / Head of Communications

+41 61 264 34 85

Board and Executive Management

Introducing Interpharma

Annual report

Information on our key figures and activities in the financial year 2020

Contact

Vision and Mission

More about the tasks and overriding aims of Interpharma

Publications

Order and download publications.